Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Frontiers in Allergy
|
February 9, 2023
The clinical and immunological basis of early food introduction in food allergy prevention
L Nuyttens, L De Vlieger, M Diels, et al.
Journal of Investigational Allergology & Clinical Immunology
|
November 8, 2023
Basophil Activation Test With Progressively Less Heated Forms of Egg Distinguishes Egg-Allergic From Egg-Tolerant Children
L De Vlieger, L Nuyttens, T Ieven, et al.
Case Reports in Immunology
|
June 3, 2022
Terminal Complement Pathway Deficiency in an Adult Patient with Meningococcal Sepsis
F Staels, W Meersseman, P Stordeur, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 18, 2019
A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real-world study in Belgium
H Lapeere, M Baeck, A Stockman, et al.
Frontiers in Allergy
|
June 12, 2023
Hereditary angioedema (HAE) in Belgium: results from a national survey
M M Van der Poorten, R Schrijvers, C Hermans, et al.
Acta Clinica Belgica
|
May 27, 2023
Clinical practice of hereditary angioedema in Belgium: opportunities for optimized care
D G Ebo, M M Van der Poorten, A L Van Gasse, et al.
Rhinology
|
February 19, 2024
Nasal hyperreactivity in allergic rhinitis and chronic rhinosinusitis with polyps: a role for neuronal pathways
W Backaert, B Steelant, T Wils, et al.
Journal of Clinical Immunology
|
June 22, 2019
Successful Allogenic Stem Cell Transplantation in Patients with Inherited CARD9 Deficiency
F Queiroz-Telles, T Mercier, J Maertens, et al.
Clinical and Translational Allergy
|
February 12, 2019
Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement
P W Hellings, B Pugin, G Mariën, et al.
Allergy
|
April 25, 2018
Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study
M A Riedl, E Aygören-Pürsün, J Baker, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Frontiers in Allergy
|
February 9, 2023
The clinical and immunological basis of early food introduction in food allergy prevention
L Nuyttens, L De Vlieger, M Diels, et al.
Journal of Investigational Allergology & Clinical Immunology
|
November 8, 2023
Basophil Activation Test With Progressively Less Heated Forms of Egg Distinguishes Egg-Allergic From Egg-Tolerant Children
L De Vlieger, L Nuyttens, T Ieven, et al.
Case Reports in Immunology
|
June 3, 2022
Terminal Complement Pathway Deficiency in an Adult Patient with Meningococcal Sepsis
F Staels, W Meersseman, P Stordeur, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 18, 2019
A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real-world study in Belgium
H Lapeere, M Baeck, A Stockman, et al.
Frontiers in Allergy
|
June 12, 2023
Hereditary angioedema (HAE) in Belgium: results from a national survey
M M Van der Poorten, R Schrijvers, C Hermans, et al.
Acta Clinica Belgica
|
May 27, 2023
Clinical practice of hereditary angioedema in Belgium: opportunities for optimized care
D G Ebo, M M Van der Poorten, A L Van Gasse, et al.
Rhinology
|
February 19, 2024
Nasal hyperreactivity in allergic rhinitis and chronic rhinosinusitis with polyps: a role for neuronal pathways
W Backaert, B Steelant, T Wils, et al.
Journal of Clinical Immunology
|
June 22, 2019
Successful Allogenic Stem Cell Transplantation in Patients with Inherited CARD9 Deficiency
F Queiroz-Telles, T Mercier, J Maertens, et al.
Clinical and Translational Allergy
|
February 12, 2019
Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement
P W Hellings, B Pugin, G Mariën, et al.
Allergy
|
April 25, 2018
Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study
M A Riedl, E Aygören-Pürsün, J Baker, et al.
Page
of 1